Contract Option Exercises — June 17, 2026

TOTE Services' firm-fixed-price delivery order from the Maritime Administration is 85% funded ($264.2M outlaid), reducing future payment risk and providing stable multi-year revenue visibility through August 2029.

Leidos Holdings' subsidiary secured a cost-plus-fixed-fee delivery order for GOCO R&D facility management, limiting margin upside but reducing cost overrun risk, with $74.2M already outlaid and $52.2M remaining.

The firm-fixed-price contract for a complex wastewater treatment plant replacement transfers cost overrun risk to Kiewit, with no options and full obligation at award, compressing margins over the 5.5-year performance period.

TOTE Services faces fixed-price execution risk on the $309.6M NSMV V vessel contract, with 85% already funded but performance through 2029; any cost overruns would directly impact margins.

Kiewit Infrastructure West Co. bears high execution risk on the $103.3M Yosemite wastewater plant contract due to firm-fixed-price pricing and complex construction scope, with full obligation at award limiting flexibility.

Leidos Biomedical Research's $126.4M NIH NCI contract expires in August 2024, creating revenue gap risk if not renewed; NIH budget appropriations for FY2024 and beyond are critical to monitor.

The $539.3M total is heavily concentrated in a single civilian award (TOTE Services at 57% of total), with no defense-related contracts above $100M, limiting sector diversification.

TOTE Services' NSMV V award positions it for follow-on NSMV or similar vessel contracts from the Maritime Administration, given the program's multi-vessel nature and TOTE's proven execution on earlier vessels.

Leidos Biomedical Research's NIH NCI facility management contract could lead to follow-on awards for GOCO R&D facility operations, given stable NIH funding for cancer research and Leidos' incumbent position.

Kiewit Infrastructure's Yosemite wastewater plant award signals continued National Park Service investment in large infrastructure projects, potentially leading to follow-on contracts for similar park infrastructure upgrades.

The $309.6M TOTE Services NSMV V award from the Maritime Administration underscores sustained federal investment in specialized vessel construction, a civilian sector with stable demand but fixed-price execution risk.

Leidos Biomedical Research's $126.4M cost-plus-fixed-fee contract for NIH NCI GOCO facility management highlights stable, low-risk revenue from federal life sciences R&D support, with cost-plus pricing reducing execution risk.

Kiewit Infrastructure's $103.3M firm-fixed-price contract for Yosemite wastewater plant replacement reflects ongoing NPS investment in aging park infrastructure, though fixed-price risk is elevated for complex construction projects.

{"entity"=>"TOTE Services, LLC", "reason"=>"NSMV V contract execution risk and potential for follow-on vessel awards from Maritime Administration", "trigger"=>"Quarterly earnings disclosures for cost overruns or delays; Maritime Administration NSMV program announcements"}

{"entity"=>"Leidos Holdings, Inc.", "reason"=>"NIH NCI GOCO facility management contract expires August 2024, creating revenue gap risk", "trigger"=>"Re-compete announcement or contract extension from NIH NCI; FY2024 NIH budget appropriations"}

{"entity"=>"Kiewit Infrastructure West Co.", "reason"=>"High execution risk on $103.3M Yosemite wastewater plant fixed-price contract", "trigger"=>"Subcontractor awards or material procurement announcements; quarterly earnings for project cost overrun disclosures"}

{"entity"=>"Maritime Administration", "reason"=>"Dominant agency in this stream with $309.6M award; budget cuts or program changes could impact TOTE Services", "trigger"=>"FY2027 budget proposals; NDAA provisions for NSMV program; any contract modifications to TOTE's award"}